Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arya, Mukesh C
NOVA-II, NCT04088318: A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients	Active, not recruiting	2	170	US, RoW	OQL011, Vehicle Ointment	OnQuality Pharmaceuticals (USA) LLC	Hand-Foot Skin Reaction (HFSR)	02/24	06/24
TEJAS-2, NCT06760702: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal, Ovarian, and Renal Cancers	Recruiting	2	90	RoW	AUR109 200mg, AUR109 300mg, AUR109 400mg	Aurigene Discovery Technologies Limited	Ovarian Cancer, Colorectal Cancer, Renal Cancer	09/26	05/27